BamSEC and AlphaSense Join Forces
Learn More

Eikon Therapeutics Inc. – Material Contracts

NASDAQ: EIKN    
Share price (6/2/26): $9.60    
Market cap (6/2/26): $520 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-K 45 pages Eikon Therapeutics, Inc. 2026 Long-Term Incentive Plan
12/34/56
EX-10.9
from S-1/A 11 pages Executive Employment Agreement
12/34/56
EX-10.8
from S-1/A 11 pages Executive Employment Agreement
12/34/56
EX-10.7
from S-1/A 12 pages Executive Employment Agreement
12/34/56
EX-10.5
from S-1/A 21 pages Eikon Therapeutics, Inc. Notice of Stock Option Grant
12/34/56
EX-10.4
from S-1/A 22 pages Eikon Therapeutics, Inc. Amended and Restated Notice of Stock Option Grant
12/34/56
EX-10.3
from S-1/A 15 pages Eikon Therapeutics, Inc. 2026 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 36 pages Eikon Therapeutics, Inc. 2026 Long-Term Incentive Plan
12/34/56
EX-10.1
from S-1/A 47 pages Eikon Therapeutics, Inc. 2019 Equity Incentive Plan as Adopted by the Board of Directors and Stockholders on September 19, 2019, and as Amended and Restated by the Board of Directors and Stockholders Through April 2, 2025
12/34/56
EX-10.18
from S-1 39 pages Certain Information in This Document, Marked by [***], Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10)(iv). Such Excluded Information Is Not Material and Is the Type That the Registrant Treats as Private or Confidential. Clinical Trial Collaboration and Supply Agreement by and Between Msd International Business Gmbh and Collaborator (As Defined Below) Clinical Trial Collaboration and Supply Agreement - Information Sheet
12/34/56
EX-10.17
from S-1 50 pages Clinical Trial Collaboration and Supply Agreement
12/34/56
EX-10.16
from S-1 4 pages November 28 , 2023
12/34/56
EX-10.15
from S-1 6 pages First Amendment to Lease
12/34/56
EX-10.14
from S-1 60 pages Lease Agreement
12/34/56
EX-10.13
from S-1 45 pages Clinical Trial Collaboration and Supply Agreement by and Between Msd International Business Gmbh and Collaborator (As Defined Below) Clinical Trial Collaboration and Supply Agreement - Information Sheet
12/34/56
EX-10.12
from S-1 3 pages Amendment One to the Amended and Restated Collaboration Agreement Between Impact Therapeutics (Shanghai), Inc. and Eikon Therapeutics, Inc
12/34/56
EX-10.11
from S-1 86 pages Amended and Restated Collaboration Agreement Between Impact Therapeutics (Shanghai), Inc. and Eikon Therapeutics, Inc. Dated as of November 22, 2023
12/34/56
EX-10.10
from S-1 36 pages Exclusive License and Development Agreement Among Superb Wisdom Limited and Eikon Therapeutics, Inc. and Seven and Eight Biotherapeutics Corp. and Birdie Biopharmaceuticals Inc. and Birdie Biotherapeutics Hk Limited, Birdie Biopharmaceuticals Co. Limited, Seven and Eight Biopharmaceuticals Inc., Birdie Biopharmaceuticals Hk Limited, Birdie Biotechnology (Bvi Limited), Birdie Biotechnology Hk Limited, and Birdie Biopharmaceuticals (Beijing) Co., Ltd
12/34/56
EX-10.9
from S-1 4 pages Amendment Number 1 to the Exclusive Collaboration Agreement
12/34/56
EX-10.8
from S-1 68 pages Exclusive Collaboration Agreement Between Seven and Eight Biotherapeutics Corp. and Birdie Biopharmaceuticals Inc. and Birdie Biotherapeutics Hk Limited, Birdie Biopharmaceuticals Co. Limited, Seven and Eight Biopharmaceuticals Inc., Birdie Biopharmaceuticals Hk Limited, Birdie Biotechnology (Bvi Limited), Birdie Biotechnology Hk Limited, and Birdie Biopharmaceuticals (Beijing) Co., Ltd. and Eikon Therapeutics, Inc. Dated as of March 29, 2023
12/34/56